The plasmid determinant of resistance to fosfomycin (For) was cloned into pBR322 and located in a 0.7-kilobase segment of DNA by transposon mutagenesis and in vitro deletion analysis. It encodes an 18-kilodalton protein located in the cytoplasm of resistant ceUs. Its synthesis is constitutive. The For genetic determinant is common to all plasmids isolated since 1975 in an hospital environment as determined by DNA-DNA hybridization. However, plasmids which carry For can be divided into two groups on the basis of size, pattern of antibiotic resistances, incompatibility specificity, and restriction and hybridization properties.
Fosfomycin [(1,2-epoxypropyl)phosphonic acid] is a broad-spectrum antibiotic produced by some strains of Streptomyces fradiae (11) that acts at the level of phosphoenolpyruvate:UDP-N-acetylglucosamine enolpyruvil transferase in the biosynthesis of peptidoglycan, thus impairing cell wall biosynthesis in bacteria (14) . Its lack of toxicity together with its virtual complete elimination through glomerular filtration (15) justified its use in a variety of bacterial infections in Spanish hospitals (26) . Use of the drug was followed by the appearance of fosfomycin-resistant (For) strains. Resistance to the antibiotic is mainly exerted through two mechanisms: (i) impermeability owing to chromosomal mutations affecting the hexose-6-phosphate or La-glycerophosphate uptake systems (13, 29) or (ii) plasmidencoded resistance by mechanisms other than transport (17) which have recently been identified as due to drug modification (18) . Plasmids carrying fosfomycin resistance have been found in Serratia marcescens and more recently in Klebsiella pneumoniae clinical strains. They have a high molecular weight, are conjugative, and carry resistances to other antibiotics (9, 21) . A transposon, Tn2921, carrying the For determinant has been identified in one of these plasmids, indicating a further means of dispersion of the resistance (7) .
Our interest in this system started with the fact that no other examples of plasmid-encoded resistance to fosfomycin have been reported although it had been looked for (23, 30, 31) and aimed to elucidate the genetics and biochemistry underlying the system. In this paper we describe the cloning of the fosfomycin resistance determinant from plasmid pUO430 into pBR322 and the subsequent location of the gene through in vitro deletion and insertion analysis as well as transposon mutagenesis. The expression of the product of this gene in minicells, its identification, and its location in the cytoplasmic fraction are also reported. We used the cloned For gene as a probe to determine whether all the For plasmids share the same genetic determinant and to investigate relationships among the plasmids, which presently all come from a single hospital.
MATERIALS AND METHODS
Plasmids, bacterial strains, and growth conditions. The plasmids used are listed in Table 1 . All were harbored by Salmonella paratyphi B777 Rif. Escherichia coli HB101 (leu pro recA rpsL thi) (20) (8) . Minicell experiments were conducted with E. coli AR1062 (F-leu minA minB rpsL thi thr) (kindly supplied by T. Thompson, Biogen, Geneva). E. coli 185 Nalr was used as the recipient in conjugation experiments. All E. coli isolates were K-12-derived strains. Cultures were grown in enriched L broth (22) or M9 minimal medium (22) at 37°C under aeration. Carbon sources (0.2%), amino acids (0.01%), and vitamin B1 (0.001%) were added to minimal media as appropriate. To select for antibiotic resistance the following concentrations were used: ampicillin (Amp), 100 gxg/ml; fosfomycin, 100 ,g/ml; nalidixic acid (Nal), 100 ,ug/ml; sulfadiazine, 300 p,g/ml; and tetracycline, 15 ,g/ml.
Genetic techniques. Conjugations were carried out as described in reference 10. Transformations were done essentially according to the procedure described in reference 19.
DNA techniques. Plasmid DNA was isolated by the cleared-lysate method of Clewell and Helinski (3), followed by CsCl-ethidium bromide centrifugation. For small-scale preparations the rapid method of Birnboim and Doly (1) was applied.
Restriction endonucleases were supplied by Boehringer Mannheim GmbH or Ingenasa and used under the conditions specified by the supplier. Analysis of plasmid DNA fragments was performed by electrophoresis in 90 mM Tris borate-2 mM EDTA (pH 8.0) on horizontal slab gels of 0.6 or 1.0% agarose. Gels were run at 30 V constant voltage overnight and stained with 0.2 ,ug of ethidium bromide per ml. Fragment sizes were determined relative to HindlIlgenerated fragments of X DNA. DNA restriction fragments were transferred from agarose gels to nitrocellulose filters (BA 85; Schleicher & Schuell, Inc., Keene, N.H.) by Southern blotting (27) .
DNA-DNA hybridizations were performed after nick translation (25) of the DNA used as a probe with 32P-labeled dCTP essentially as described previously (20) at 65°C overnight. Ligation with T4 DNA ligase was performed as described previously (28) .
Isolation of plasmids carrying an inserted y8 transposable element. Plasmids with yb insertions were isolated as described previously (8) . Strain LC707 carrying an F plasmid was transformed to Ampr For with transfer-deficient plasmid pUO001. One transformant was used as the donor in a conjugation experiment, taking advantage of the mobiliza- tion capacities of F in pUO001, using E. coli 185 Nalr as the recipient and selecting for Ampr and Nair. Colonies growing in selective medium were then tested for Fos. Plasmid DNA was extracted from the transconjugants, and the yb insertions were localized with SalGI-, PstI-, and HindlIlgenerated restriction fragments. Minicell techniques. Minicell isolation was done as previously described (5). Plasmid-encoded proteins were labeled in Hershey medium (Tris base, 12.1 g; NaCl, 5.4 g; KCl, 3.0 g; NH4Cl, 1.1 g; CaCl2 * 2H20, 0.015 g; MgCl2 * 6H20, 0.203 g; FeCl3 * 6H20, 0.0002 g; KH2PO4, 0.087 g; H20, liter) with [35S]methionine (1,103.2 Ci/mmol; New England Nuclear Corp., Boston, Mass.), extracted from the minicells by sodium dodecyl sulfate-mediated lysis and loaded onto a polyacrylamide-sodium dodecyl sulfate gel (15%) with a 5% stacking gel (16) . The electrophoresis was run at 40 V constant voltage for 14 h.
After electrophoresis, the gels were fixed, fluorographed with sodium salicylate, and dried onto filter paper (2). Labeled proteins were visualized by exposing gels for 2 to 3 days to Kodak X-Omat S film. Molecular weights were estimated by comparison with a set of standard proteins: bovine serum albumin, 67,000; ovalbumin, 45,000; Ilactoglobulin, 18 ,400; lysozyme, 14,300 (Sigma Chemical Co., St. Louis, Mo.).
Osmotic shock procedure and fractionation of minicells. The shock procedure of Heppel (12) was used to obtain the periplasmic fraction of minicells harboring plasmid pUO001. Minicells were obtained from 500 ml of culture medium and labeled with [35S]methionine. These were then fractionated as described by Osborn and Munson (24) , through conversion to spheroplasts with lysozyme and dilution with EDTA followed by osmotic lysis and separation through repeated centrifugation of the cytoplasmic and membrane fractions. The fractions obtained were then vacuum dried, solubilized in Laemmli lysis buffer (16) , run in polyacrylamide gels, and fluorographed as described above. RESULTS Cloning of the determinant of resistance to fosfomycin into pBR322. The determinant of resistance to fosfomycin, carried by plasmid pUO430, was cloned into pBR322 as a BamHI fragment of 3.7 kilobases (kb). The hybrid plasmid was named pUO001 and upon transformation conferred resistance to ampicillin and fosfomycin but not to tetracycline, as expected. The restriction map of pUO001 is diagrammed in Fig. 1 pBR322 and a segment from the insertion of 1.4 kb (Fig. 1 ) that carried For because the transformation of the plasmid to susceptible cells always rendered them resistant. Cloning of sulfonamide resistance into the BgllI site of pUO001. A BamHI segment of pUO430 carrying the Sur determinant (unpublished data) was cloned into the BglII site of pUO001. The resultant plasmid, pUO004, carried both For and Sur, indicating that the BglII site was outside of the For site which was then putatively located in the 1-kb segment that was between the BgIII and PstI sites of the pUO430 part of pUO001 (Fig. 1) .
Transposon mutagenesis of fosfomycin resistance. To obtain a more precise location of the determinant of resistance to fosfomycin as well as to identify the protein responsible for resistance, the sequence yb of plasmid F was inserted into pUO001 as described in Materials and Methods. Of 60 colonies tested all showed a plasmid of 13.7 kb corresponding to the sum of pUO001 plus yb. The location of -yb was analyzed by restriction of the plasmids with PstI, SalGI, and HindlIl. The locations of 13 insertions into pUO001 are indicated in Fig. 2 . It can be seen that all the insertions giving a higher degree of susceptibility to fosfomycin than pUO001 map between the BgIII and PstI sites of the insertion, confirming the genetic data described above.
On (Fig. 3B ). The biosynthesis of the polypeptide seems to be constitutive because no changes in the intensity of the band were seen when the cells or the minicells were incubated in the absence or presence of fosfomycin (Fig. 3A) . The location of the 18-kDa polypeptide in minicells was done by fractionation and analysis of the labeled proteins of the fractions (Fig. 4) found several plasmids in clinical isolates of S. marcescens and more recently of K. pneumoniae which carried determinants of resistance to fosfomycin. To establish the degree of identity among these plasmids as well as of their fosfomycin resistance determinants, four representatives of the different groups encountered in successive screenings (based on R phenotype, size, host of first isolation, and incompatibility group) were chosen. These plasmids were pUO900, pUO500, pUO200, and pUO430 and their characteristics are included in Table 1 .
To test whether resistance to fosfomycin carried by all these plasmids had a genetic relationship, their DNA was cleaved with BamHI and PstI (Fig. 5) , blotted to nitrocellulose paper, and hybridized with nick-translated 32P-labeled DNA from plasmid pUOO1. There was a positive result with all the plasmids (Fig. 6A) , presumably indicating that the determinant of resistance to fosfomycin is homologous in all the plasmids of the pUO series. Surprisingly, two BamHI restriction fragments of pUO430 had positive hybridization (lane 3), and, since in pUOO1 there is only one BamHI fragment from pUO430, this could indicate that pBR322 itself had some homology with pUO430. On the other hand, the BamHI insertion of pUOOO1 has an internal PstI site, and consequently two PstI bands of pUO430 were expected to show positive hybridization. Figure 6A the plasmids it strongly indicates that the For genetic determinant is also common to all of them. On the other hand, two PstI fragments hybridized with the pBR322 probe (lane 3), so the other two should correspond to the fragment carrying For.
Homology among representative plasmids of the pUO series. Figure 5 shows a restriction analysis of the prototype plasmids of the pUO series with several restriction enzymes. A quite similar pattern of restriction fragments was observed between plasmids pUO430 and pUO900 and between pUO200 and pUO500, although there were obvious differences between both sets. This result was confirmed by hybridization analysis of the plasmid DNA with in vitro FIG. 7. Hybridization of the plasmids shown in Fig. 5 with plasmid pUO430. Lanes 1, 2, 3, and 4: BamHI digestion of pUO200, pUO500, pUO430, and pUO900, respectively. Lanes 5, 6, 7, and 8: HindIII digestion of the same respective plasmids. 32P-labeled pUO430 (Fig. 7) and pUO200 (Fig. 8) . It was clear that all the restriction fragments of pUO900 showed positive hybridization with radioactive pUO430. On the contrary, very weak hybridization was seen with plasmids pUO500 and pUO200. The intensity of hybridization of radioactive pUO200 was much stronger with itself and with pUO500 than with the rest of the plasmids. The bands of pUO430 and pUO900 hybridizing strongly with radioactive pUO200 corresponded to segments of DNA presumably carrying determinants of resistance common to all the plasmids as has been in part determined by their positive hybridization with pBR322 (see above). DISCUSSION The existence of plasmid-borne resistance to fosfomycin was initially reported because it was capable of being transferred by conjugation to susceptible strains (21) . The resistance is not exerted through a permeability barrier to the drug, as is chromosomally mediated resistance (29) Cloning of the determinant of resistance to fosfomycin gives a practical advantage in epidemiological studies because it can be used as a genetic probe for the evaluation of the dispersion of the gene among plasmids and bacterial species not only in our environment, but also in other places where the use of fosfomycin is becoming common (4) . In fact, it has been used to determine that all the plasmids conferring For and isolated in our community carry the same determinant of resistance, independent of their genetic homology, incompatibility group, and species of first isolation.
This finding could be most easily explained by assuming that transposon Tn2921 carrying For and identified by Garcia-Lobo and Ortiz (7) in pUO900 could be present in all the plasmids. This hypothesis has been in part confirmed by the finding of Garcia-Lobo et al. (6) , who starting from Tn2921, have found that the For it carries is conferred by a single polypeptide of 16 kDa, probably the same that we identified in pUO430 as 18 kDa. Unfortunately, several attempts to recover the transposon from pUO200 and pUO430 have failed.
With respect to the plasmids isolated from clinical strains, it is now quite clear that two groups can be distinguished. The first group includes plasmids of high molecular weight, represented by pUO500 isolated in 1975 in S. marcescens and by pUO200 found in strains of K. pneumoniae since 1980. We assume that pUO200 and pUO500 are different forms of a similar replicon. They were isolated from different enterobacteria and have different molecular weights but belong to the same incompatibility group, carry the same antibiotic resistances, and possess a remarkably similar pattern of restriction. Furthermore, all the restriction fragments generated in pUO500 show positive hybridization with radioactive pUO200. Plasmids of the second series also showed a close relationship among themselves but only a slight one with the plasmids of the first group. Both prototypes, pUO900 and pUO430, seemed to be very similar by restriction and hybridization analysis despite differences in size and pattern of resistances. Because pUO900 was found for the first time in strains of S. marcescens isolated in 1975 and pUO430 was found in 1981, it is assumed that the latter plasmid derives from pUO900 with the acquisition of an 8-megadalton insertion (pUO430 is 65 megadaltons while pUO900 is 57 megadaltons) that should carry the determinants of resistance to gentamicin, chloramphenicol, and sulfadiazine absent from pUO900.
Common antibiotic resistances among the plasmids of both groups could also explain the weak signal found when radioactive plasmids of one group are hybridized with the plasmids of the other, as well as their positive hybridization with pBR322. In this respect, it has been determined that the P-lactamases of all the pUO plasmids and the corresponding enzyme of pBR322 are of the same kind by isoelectric focusing (F. Fierro, personal communication), and consequently the genes encoding them are probably related.
